Status:
COMPLETED
Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
Lead Sponsor:
Valerio Therapeutics
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the clinical cure of miconazole Lauriad 50 mg (1x50mg) Bioadhesive buccal tablets compared with clotrimazole troches (5x10mg) after 14 days of treatment (at th...
Eligibility Criteria
Inclusion
- Patients with clinical picture of oropharyngeal candidiasis
- Confirmation of oropharyngeal candidiasis by candida culture positive
- HIV-positive patients
- Patients 18 years of age
Exclusion
- Patients with signs or symptoms of systemic candidiasis
- Patients with signs or symptoms of esophagitis
- Pregnant or breast-feeding women
- Patients who have taken systemic antifungals within the past 30 days
- Patients who have taken local antifungals within the past 7 days
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
578 Patients enrolled
Trial Details
Trial ID
NCT00390780
Start Date
July 1 2006
End Date
January 1 2008
Last Update
September 16 2013
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama, Department of diagnostic Sciences School of Dentistry
Birmingham, Alabama, United States, 35294-00007
2
L.A. Gay & Lesbian center, Health & Mental, health services
Los Angeles, California, United States, 90028
3
East Bay AIDS Center
Oakland, California, United States, 94609
4
1401 Noth Palm Canyon
Palm Springs, California, United States, 92262